PARP1 and cancer: For this reason, the identification of predictive biomarkers and the ability to overcome PARP1 inhibitor resistance will be crucial to enable further optimization of PARP1 inhibitors for cancer therapy; moreover, understanding PARP1 relation network could expand utility of PARP1 inhibitors also to other cancers where these interactors or related pathways are altered.